Inside nerve cells, magnesium binds to specific sites on BK potassium channels, making them more likely to open when calcium levels rise, which helps the cell recover after firing and prevents overexcitation.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether magnesium supplementation improves neuronal repolarization and reduces seizure frequency in humans with BK channelopathies like epilepsy or ataxia.
A systematic review and meta-analysis of all clinical trials in patients with KCNMA1 mutations (BK channelopathies) comparing oral magnesium (300–500 mg/day) versus placebo for 6 months, with primary outcomes: seizure frequency, ataxia scale scores, and EEG abnormalities.
Whether IV magnesium enhances BK channel-mediated repolarization in human cortical neurons during simulated ischemia.
A double-blind RCT in 30 patients undergoing carotid endarterectomy, randomized to IV magnesium sulfate (10 mmol) or saline, with cortical neuron repolarization measured via intraoperative electrocorticography and BK channel blocker (paxilline) sensitivity.
Whether low intracellular magnesium in cortical neurons predicts reduced BK channel activity and increased excitability in patients with Alzheimer’s disease.
A prospective cohort of 100 patients with early Alzheimer’s and 100 age-matched controls, measuring intracellular magnesium in post-mortem cortical tissue and BK channel current density via patch-clamp, adjusting for age and APOE status.
Whether patients with familial hemiplegic migraine have altered BK channel sensitivity to magnesium compared to controls.
A case-control study comparing BK channel gating in induced pluripotent stem cell-derived cortical neurons from 20 patients with CACNA1A mutations (familial hemiplegic migraine) and 20 controls, with and without intracellular magnesium manipulation.
Whether serum magnesium correlates with cortical excitability in healthy adults, measured by transcranial magnetic stimulation and BK channel pharmacology.
A cross-sectional study of 200 healthy adults, measuring serum magnesium and cortical excitability via TMS (SICI and ICF), with and without intravenous paxilline (BK blocker), adjusting for age, sex, and renal function.